HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hematopoietic stem cell transplantation for leukemia.

Abstract
Leukemia represents the most common pediatric malignancy, accounting for approximately 30% of all cancers in children less than 20 years of age. Most children diagnosed with leukemia are cured without hematopoietic stem cell transplantation (HSCT), but for some high-risk subgroups, allogeneic HSCT plays an important role in their therapeutic approach. The characteristics of these high-risk subgroups and the role of HSCT in childhood leukemias are discussed.
AuthorsAlan S Wayne, Kristin Baird, R Maarten Egeler
JournalPediatric clinics of North America (Pediatr Clin North Am) Vol. 57 Issue 1 Pg. 1-25 (Feb 2010) ISSN: 1557-8240 [Electronic] United States
PMID20307709 (Publication Type: Journal Article, Review)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Topics
  • Global Health
  • Hematopoietic Stem Cell Transplantation (methods)
  • Humans
  • Leukemia (mortality, surgery)
  • Survival Rate (trends)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: